Previous studies have shown that circulating levels of apelin were sufficiently lower in patients with established cardiovascular diseases (coronary artery disease, myocardial infarction, acute coronary syndrome, HF), T2DM, and obesity than in healthy volunteers [167,168]. The gene discussed is APLN; the disease is cardiovascular disorder.